Close to Launching Gene Therapy, Dutch Biotech Aims to Raise $100M on the Nasdaq – Labiotech.eu (blog)
|
Close to Launching Gene Therapy, Dutch Biotech Aims to Raise $100M on the Nasdaq
Labiotech.eu (blog) UniQure launched a public offering, perfectly timed with a rise in its stock last week after it announced a pivotal trial with a gene therapy for hemophilia. UniQure has announced it is launching an additional 5 million shares on the Nasdaq. At its … |
